Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
about
Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.Medical management of pancreatic neuroendocrine tumors.Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine.Dendritic cells fused with different pancreatic carcinoma cells induce different T-cell responsesThe first 1000 dendritic cell vaccinees.
P2860
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
@en
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
@nl
type
label
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
@en
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
@nl
prefLabel
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
@en
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
@nl
P2093
P2860
P1476
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2265.2001.01293.X
P577
2001-08-01T00:00:00Z